The RxView Blog

Real world data, analytics, and insights for healthcare decision makers

Advera Health Analytics, Inc.

What is an Evidence Aggregation Platform?

Posted by Jim Davis on Aug 25, 2016 11:00:00 AM

An evidence aggregation platform is a web based software-as-a-service (SaaS) application that takes multiple, disparate sources of data, or evidence, and combines those data together using analytics to create new insight.

For example, an evidence aggregation platform can read adverse event data points from multiple clinical trial results and perform on-demand meta-analyses to better understand side effect rates for drugs. The evidence aggregation platform can then compare side effect rates from clinical trial results to side effect rates found in real world data such as pharmacy claims data or electronic health records (EHR).

Read More

Topics: Evidex, real world data, evidence aggregation platform, clinical trial results

The Drug Pricing Battle Wages On

Posted by Brian Overstreet on Aug 19, 2016 10:30:00 AM

The battle over drug pricing took an interesting turn here in California this week.  On the heels of such negative publicity about high priced prescription drugs, giant price spikes for certain medications, and general bad behavior among certain high profile biotech executives, it’s not surprising that regulators and government bodies are starting to weigh in on ways to regulate or control drug price increases.

Read More

Topics: drug pricing

How Information on Health Care’s Value is Currently Shared

Posted by Jim Davis on Aug 9, 2016 8:00:00 AM

On August 1, 2016, Dan Leonard, the President of the National Pharmaceutical Council published an opinion piece for Morning Consult, laying out his reasons for FDA to provide guidance on how biopharmaceutical companies can utilize and share real-world evidence with healthcare decision makers. He argues that due to shortcomings and ambiguities in existing laws, the exchange of information is limited, and stakeholders are making decisions without access to all of the pertinent information.  His solution is more regulation and guidance from FDA.

Read More

Topics: Real World Evidence, Evidex

Express Scripts’ 2017 Exclusions – Analysis Using Real World Data

Posted by Jim Davis on Aug 2, 2016 4:30:28 PM

It has become tradition at Advera Health to look closely at the annual formulary exclusions that the large payers such as Express Scripts introduce every August. Using our safety scoring and costing algorithms we are able to quickly provide a top-line view into the effects of their decisions. 

Read More

Topics: Drug Safety, Drug Formulary, Express Scrips, RxCost

Summer Slowdown? No, Summer Build!

Posted by Brian Overstreet on Jul 29, 2016 10:30:00 AM

As we hit the end of July, it seems that the summer slowdown is in full effect.  For every ten emails I send out I get back at least six “out of office” replies.  As with any organization focused on building and supporting a client base, it’s hard not to get a little anxious in August when calls aren’t returned, contracts aren’t processed, and just about everything grinds to a halt.

Read More

Safety Score & Cost Burden Analysis Update – Which Drugs have Riskiest Profiles?

Posted by Andrea Demakas on Jul 21, 2016 10:30:00 AM

In June, the Advera analyst team combed through prescription and patient population data supplied by our partners at Evaluate Pharma to update our RxScore and RxCost analytics site-wide. The end result yielded 53 drugs with first-time RxScores and 69 drugs with first-time RxCosts.

Read More

Topics: RxScore, P&T, RxCost

Guest Post: BBK Talks #BigData with Advera Health Analytics

Posted by Brian Overstreet on Jul 15, 2016 11:00:00 AM

This post was originally published on the BBK Worldwide Blog.

Big Data was a Big Topic at this year’s DIA Annual Meeting, and continues to be an area of interest and investment across the life sciences and healthcare industries as organizations seek to further integrate new data streams and real-time analysis into clinical R&D. Data collection, management and analysis are at the crux of everything we do here at BBK, and our clients are keenly interested in how to manage and optimize Big Data. We interviewed Brian Overstreet, CEO of Advera Health Analytics, a leading healthcare informatics company, to get their take and to see how access to meaningful data is helping to push healthcare forward. 

Read More

Topics: Big Data, patient safety

Chronic Underreporting of Clinical Trials

Posted by Brian Overstreet on Jul 8, 2016 10:30:00 AM

Well, now we’re getting somewhere!

Read More

Topics: MS, NIH

Honest Salespeople Aren’t Dead

Posted by Andrea Demakas on Jun 24, 2016 10:30:00 AM

I’m writing this in the lobby of a car dealership, waiting for my vehicle to get serviced. I brought a couple of sales books with me so I could utilize the 2 hour wait. I recently took on the added role of part-time sales rep within Advera Health as I have experienced successful case studies first-hand through being our client-facing Product Specialist over the past two years: I’ve built relationships with our existing clients, received their feedback on our data tools & analytics to see how they’ve implemented the information, and witnessed how our Evidex platform has become an integral part of their workflow.

Read More

Topics: FAERS, Payers, Formulary, Providers, Evidex

How to Make Sense of the ADA Conference Data Deluge

Posted by Jim Davis on Jun 16, 2016 7:30:00 AM

Every June, on the heels of the ASCO annual conference, comes the American Diabetes Association (ADA) annual conference, with a data deluge that is difficult for even the most diligent industry watchers to keep up with. At time of writing, it is only midday on Tuesday and there are already huge headlines from the conference.

Read More

Topics: Diabetes, Clinical Evidence, Evidex

Subscribe to Email Updates